Report Detail
Global Transdermal Drug Delivery Formulation Market Growth (Status and Outlook) 2023-2029
- RnM4532509 |
- 23 May, 2023 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The global Transdermal Drug Delivery Formulation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Transdermal Drug Delivery Formulation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Transdermal Drug Delivery Formulation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Transdermal Drug Delivery Formulation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Transdermal Drug Delivery Formulation players cover Johnson & Johnson, Mylan, Echo Therapeutics, Novartis, GSK, Hunan Jiudian, Tide Pharmaceutical, Luye Pharma and GDB, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Transdermal Drug Delivery Formulation Industry Forecast” looks at past sales and reviews total world Transdermal Drug Delivery Formulation sales in 2022, providing a comprehensive analysis by region and market sector of projected Transdermal Drug Delivery Formulation sales for 2023 through 2029. With Transdermal Drug Delivery Formulation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transdermal Drug Delivery Formulation industry.
This Insight Report provides a comprehensive analysis of the global Transdermal Drug Delivery Formulation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transdermal Drug Delivery Formulation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transdermal Drug Delivery Formulation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transdermal Drug Delivery Formulation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transdermal Drug Delivery Formulation.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Delivery Formulation market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Ointment
Glue
Cataplasm
Other
Segmentation by application
Hospital
Drug Store
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Mylan
Echo Therapeutics
Novartis
GSK
Hunan Jiudian
Tide Pharmaceutical
Luye Pharma
GDB
Anssure Pharma
Novastage
LIANSN
KBD
CosMED Pharmaceutical
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Transdermal Drug Delivery Formulation Market Size 2018-2029
- 2.1.2 Transdermal Drug Delivery Formulation Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Transdermal Drug Delivery Formulation Segment by Type
- 2.2.1 Ointment
- 2.2.2 Glue
- 2.2.3 Cataplasm
- 2.2.4 Other
- 2.3 Transdermal Drug Delivery Formulation Market Size by Type
- 2.3.1 Transdermal Drug Delivery Formulation Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Transdermal Drug Delivery Formulation Market Size Market Share by Type (2018-2023)
- 2.4 Transdermal Drug Delivery Formulation Segment by Application
- 2.4.1 Hospital
- 2.4.2 Drug Store
- 2.4.3 Other
- 2.5 Transdermal Drug Delivery Formulation Market Size by Application
- 2.5.1 Transdermal Drug Delivery Formulation Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Transdermal Drug Delivery Formulation Market Size Market Share by Application (2018-2023)
3 Transdermal Drug Delivery Formulation Market Size by Player
- 3.1 Transdermal Drug Delivery Formulation Market Size Market Share by Players
- 3.1.1 Global Transdermal Drug Delivery Formulation Revenue by Players (2018-2023)
- 3.1.2 Global Transdermal Drug Delivery Formulation Revenue Market Share by Players (2018-2023)
- 3.2 Global Transdermal Drug Delivery Formulation Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Transdermal Drug Delivery Formulation by Regions
- 4.1 Transdermal Drug Delivery Formulation Market Size by Regions (2018-2023)
- 4.2 Americas Transdermal Drug Delivery Formulation Market Size Growth (2018-2023)
- 4.3 APAC Transdermal Drug Delivery Formulation Market Size Growth (2018-2023)
- 4.4 Europe Transdermal Drug Delivery Formulation Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Transdermal Drug Delivery Formulation Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Transdermal Drug Delivery Formulation Market Size by Country (2018-2023)
- 5.2 Americas Transdermal Drug Delivery Formulation Market Size by Type (2018-2023)
- 5.3 Americas Transdermal Drug Delivery Formulation Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Transdermal Drug Delivery Formulation Market Size by Region (2018-2023)
- 6.2 APAC Transdermal Drug Delivery Formulation Market Size by Type (2018-2023)
- 6.3 APAC Transdermal Drug Delivery Formulation Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Transdermal Drug Delivery Formulation by Country (2018-2023)
- 7.2 Europe Transdermal Drug Delivery Formulation Market Size by Type (2018-2023)
- 7.3 Europe Transdermal Drug Delivery Formulation Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Transdermal Drug Delivery Formulation by Region (2018-2023)
- 8.2 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Transdermal Drug Delivery Formulation Market Forecast
- 10.1 Global Transdermal Drug Delivery Formulation Forecast by Regions (2024-2029)
- 10.1.1 Global Transdermal Drug Delivery Formulation Forecast by Regions (2024-2029)
- 10.1.2 Americas Transdermal Drug Delivery Formulation Forecast
- 10.1.3 APAC Transdermal Drug Delivery Formulation Forecast
- 10.1.4 Europe Transdermal Drug Delivery Formulation Forecast
- 10.1.5 Middle East & Africa Transdermal Drug Delivery Formulation Forecast
- 10.2 Americas Transdermal Drug Delivery Formulation Forecast by Country (2024-2029)
- 10.2.1 United States Transdermal Drug Delivery Formulation Market Forecast
- 10.2.2 Canada Transdermal Drug Delivery Formulation Market Forecast
- 10.2.3 Mexico Transdermal Drug Delivery Formulation Market Forecast
- 10.2.4 Brazil Transdermal Drug Delivery Formulation Market Forecast
- 10.3 APAC Transdermal Drug Delivery Formulation Forecast by Region (2024-2029)
- 10.3.1 China Transdermal Drug Delivery Formulation Market Forecast
- 10.3.2 Japan Transdermal Drug Delivery Formulation Market Forecast
- 10.3.3 Korea Transdermal Drug Delivery Formulation Market Forecast
- 10.3.4 Southeast Asia Transdermal Drug Delivery Formulation Market Forecast
- 10.3.5 India Transdermal Drug Delivery Formulation Market Forecast
- 10.3.6 Australia Transdermal Drug Delivery Formulation Market Forecast
- 10.4 Europe Transdermal Drug Delivery Formulation Forecast by Country (2024-2029)
- 10.4.1 Germany Transdermal Drug Delivery Formulation Market Forecast
- 10.4.2 France Transdermal Drug Delivery Formulation Market Forecast
- 10.4.3 UK Transdermal Drug Delivery Formulation Market Forecast
- 10.4.4 Italy Transdermal Drug Delivery Formulation Market Forecast
- 10.4.5 Russia Transdermal Drug Delivery Formulation Market Forecast
- 10.5 Middle East & Africa Transdermal Drug Delivery Formulation Forecast by Region (2024-2029)
- 10.5.1 Egypt Transdermal Drug Delivery Formulation Market Forecast
- 10.5.2 South Africa Transdermal Drug Delivery Formulation Market Forecast
- 10.5.3 Israel Transdermal Drug Delivery Formulation Market Forecast
- 10.5.4 Turkey Transdermal Drug Delivery Formulation Market Forecast
- 10.5.5 GCC Countries Transdermal Drug Delivery Formulation Market Forecast
- 10.6 Global Transdermal Drug Delivery Formulation Forecast by Type (2024-2029)
- 10.7 Global Transdermal Drug Delivery Formulation Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Company Information
- 11.1.2 Johnson & Johnson Transdermal Drug Delivery Formulation Product Offered
- 11.1.3 Johnson & Johnson Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Johnson & Johnson Main Business Overview
- 11.1.5 Johnson & Johnson Latest Developments
- 11.2 Mylan
- 11.2.1 Mylan Company Information
- 11.2.2 Mylan Transdermal Drug Delivery Formulation Product Offered
- 11.2.3 Mylan Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Mylan Main Business Overview
- 11.2.5 Mylan Latest Developments
- 11.3 Echo Therapeutics
- 11.3.1 Echo Therapeutics Company Information
- 11.3.2 Echo Therapeutics Transdermal Drug Delivery Formulation Product Offered
- 11.3.3 Echo Therapeutics Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Echo Therapeutics Main Business Overview
- 11.3.5 Echo Therapeutics Latest Developments
- 11.4 Novartis
- 11.4.1 Novartis Company Information
- 11.4.2 Novartis Transdermal Drug Delivery Formulation Product Offered
- 11.4.3 Novartis Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Novartis Main Business Overview
- 11.4.5 Novartis Latest Developments
- 11.5 GSK
- 11.5.1 GSK Company Information
- 11.5.2 GSK Transdermal Drug Delivery Formulation Product Offered
- 11.5.3 GSK Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 GSK Main Business Overview
- 11.5.5 GSK Latest Developments
- 11.6 Hunan Jiudian
- 11.6.1 Hunan Jiudian Company Information
- 11.6.2 Hunan Jiudian Transdermal Drug Delivery Formulation Product Offered
- 11.6.3 Hunan Jiudian Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Hunan Jiudian Main Business Overview
- 11.6.5 Hunan Jiudian Latest Developments
- 11.7 Tide Pharmaceutical
- 11.7.1 Tide Pharmaceutical Company Information
- 11.7.2 Tide Pharmaceutical Transdermal Drug Delivery Formulation Product Offered
- 11.7.3 Tide Pharmaceutical Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Tide Pharmaceutical Main Business Overview
- 11.7.5 Tide Pharmaceutical Latest Developments
- 11.8 Luye Pharma
- 11.8.1 Luye Pharma Company Information
- 11.8.2 Luye Pharma Transdermal Drug Delivery Formulation Product Offered
- 11.8.3 Luye Pharma Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Luye Pharma Main Business Overview
- 11.8.5 Luye Pharma Latest Developments
- 11.9 GDB
- 11.9.1 GDB Company Information
- 11.9.2 GDB Transdermal Drug Delivery Formulation Product Offered
- 11.9.3 GDB Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 GDB Main Business Overview
- 11.9.5 GDB Latest Developments
- 11.10 Anssure Pharma
- 11.10.1 Anssure Pharma Company Information
- 11.10.2 Anssure Pharma Transdermal Drug Delivery Formulation Product Offered
- 11.10.3 Anssure Pharma Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Anssure Pharma Main Business Overview
- 11.10.5 Anssure Pharma Latest Developments
- 11.11 Novastage
- 11.11.1 Novastage Company Information
- 11.11.2 Novastage Transdermal Drug Delivery Formulation Product Offered
- 11.11.3 Novastage Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Novastage Main Business Overview
- 11.11.5 Novastage Latest Developments
- 11.12 LIANSN
- 11.12.1 LIANSN Company Information
- 11.12.2 LIANSN Transdermal Drug Delivery Formulation Product Offered
- 11.12.3 LIANSN Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 LIANSN Main Business Overview
- 11.12.5 LIANSN Latest Developments
- 11.13 KBD
- 11.13.1 KBD Company Information
- 11.13.2 KBD Transdermal Drug Delivery Formulation Product Offered
- 11.13.3 KBD Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 KBD Main Business Overview
- 11.13.5 KBD Latest Developments
- 11.14 CosMED Pharmaceutical
- 11.14.1 CosMED Pharmaceutical Company Information
- 11.14.2 CosMED Pharmaceutical Transdermal Drug Delivery Formulation Product Offered
- 11.14.3 CosMED Pharmaceutical Transdermal Drug Delivery Formulation Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 CosMED Pharmaceutical Main Business Overview
- 11.14.5 CosMED Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Transdermal Drug Delivery Formulation. Industry analysis & Market Report on Transdermal Drug Delivery Formulation is a syndicated market report, published as Global Transdermal Drug Delivery Formulation Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Transdermal Drug Delivery Formulation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
